Delivery Order SPE2DB20D1004-SPE2DB25FNCWU

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,646.55 fixed-price delivery order is for the supply of 2.5 mg zolmitriptan tablets, a medication used to treat migraines. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,424.52 delivery order contract is for the supply of Zolmitriptan 2.5 mg tablets, a medication used to treat migraine headaches. The contract has a firm fixed price and a completion date of December 18, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,401.73 firm-fixed-price delivery order is for the supply of Zolmitriptan 5 mg tablets to support military healthcare programs. The award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $4,403.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZOLMITRIPTAN 5 MG TABLET UD 3S, a medication, to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,268.16 delivery order contract is for the supply of Zolmitriptan 5 mg orally disintegrating tablets, a medication used for the treatment of migraines. The contract has a firm-fixed price pricing type and a completion date of September 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $3,621.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,407,890 zolmitriptan 5 mg tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is a delivery order valued at $3,089.46 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of zolmitriptan 5 mg orally disintegrating tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, SPE2DB20D3103|SPE2DB24FP9T2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,032.27 firm fixed-price delivery order is for the supply of zolmitriptan 2.5 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of August 22, 2024 and was awarded on August 21, 2024. It is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.65 Firm Fixed Price Delivery Order is for the supply of 4,563,588,347 units of the medication Zolmitriptan 2.5 mg tablet, with a completion date of February 8, 2024. The award is associated with AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $1,487.04 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZOLMITRIPTN 5MG ODT 3S, a medication used to treat migraines. The award is not associated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNCWU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,401.64 firm-fixed-price delivery order is for the supply of 4566517585 ZOLMITRIPTAN 2.5 MG TABLET UD 6S, a medication used to treat migraines.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 10:43 AM